[HTML][HTML] Safety and tolerability of metastasis-directed radiation therapy in the era of evolving systemic, immune, and targeted therapies

E Guimond, CJ Tsai, A Hosni, G O'Kane, J Yang… - Advances in Radiation …, 2022 - Elsevier
AbstractPurpose: Systemic, immune, and target therapies are growing in use in the
management of metastatic cancers. The aim of this review was to describe up-to-date …

Sociodemographic, clinical profile, and treatment characteristics of oncology patients developing radiation recall phenomenon: Two tertiary care center's experience of …

A Purkayastha, N Sharma, S Taneja… - Tzu Chi Medical …, 2022 - journals.lww.com
Objectives: To determine the socio-demographic and clinical profile of cancer patients
developing radiation recall phenomenon or radiation recall dermatitis following …

[PDF][PDF] Kožní toxicita BRAF a MEK inhibitorů

M Důra - Onkologie, 2021 - onkologiecs.cz
Inhibitory mutované BRAF kinázy dohromady s inhibitory MEK kinázy jsou jednou z
alternativ moderní systémové léčby metastazujícího melanomu. BRAF a MEK inhibitory též …

“Radiation Recall Phenomenon” with Novel Cytotoxic Agents: An Emerging Trend in the Last Decade

A Mandal, P Singh, S Tandon… - Indian Journal of Medical …, 2021 - thieme-connect.com
Radiation recall phenomenon (RRP) is an acute inflammatory reaction manifested in the
previously irradiated tissues after the administration of various pharmacologic compounds …

[HTML][HTML] " Radiation Recall Phenomenon" with Novel Cytotoxic Agents: An Emerging Trend in the Last Decade

PS Kulkarni, K Das, N Agrawal, M Kala, R Khanduri… - ijmpo.org
Radiation recall phenomenon (RRP) is an acute inflammatory reaction manifested in the
previously irradiated tissues after the administration of various pharmacologic compounds …